ViroVet
PrivateLast Round
Series C
Jun 16, 2022
Total Funding Raised
$24.05M
Company Overview
ViroVet is a biotechnology company that develops innovative technologies, including antiviral drugs and vaccines, for the control of viral diseases in livestock.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViroVet Comparables
Compare ViroVet with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VEROVACCiNES GmbH | 81% | |
| The Vaccine Group | 80% | |
| Genvax Technologies | 78% | |
ViroVet Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 16, 2022 | ||||
| Series B | May 28, 2020 | ||||
| Grant | Sep 1, 2018 | ||||
| Series A Extension | Oct 4, 2017 | ||||
| Series A | Jan 10, 2017 |
Key People
Founding team and executive leadership
ViroVet Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capricorn Partners | Series B, Series C, Series A, Series A Extension |
| Gimv | Series B, Series C |
| KU Leuven Research & Development (LRD) | Series B, Series C |
| KU Leuven | Series B, Series A |
| VIVES II - Louvain Technology Fund | Series B, Series A |
| VLAIO | Grant |
| VIVES Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2022
Raised $8M from Gimv, Capricorn Partners, and others.
- May 28, 2020
$7M round led by Seventure Partners
ViroVet Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ViroVet's valuation, stock price, and market status.